Ensuring transparency and minimization of methodologic bias in preclinical pain research: PPRECISE considerations

Nick A Andrews1, Alban Latrémolière, Allan I Basbaum

  • 1Department of Neurobiology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA Department of Anatomy, University of California San Francisco, San Francisco, CA, USA Department of Psychology and Alan Edwards Centre for Research on Pain, McGill University, Montreal, Canada Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA Pain Research, Department of Surgery and Cancer, Imperial College, London, United Kingdom Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom Departments of Anesthesiology, Neurology, and Psychiatry, University of Rochester, Rochester, NY, USA Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC, USA Department of Biostatistics, Harvard University, Boston, MA, USA Department of Anesthesiology, University of Rochester, Rochester, NY, USA Clinical and Rehabilitative Medicine Research Program, United States Army Medical Research and Materiel Command, Fort Detrick, MD, USA Department of Physiology and Pathophysiology, Friedrich-Alexander Universität, Erlangen-Nürnberg, Germany Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom Eli Lilly & Co., Indianapolis, IN, USA Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA Neuroscience Discovery Research, Eli Lilly & Co., Indianapolis, IN, USA Policy Department, Wellcome Trust, London, United Kingdom Departments of Medicine and Oral Surgery, University of California San Francisco, San Francisco, CA, USA National Centre for Replacement, Refinement & Reduction of Animals in Research, London, United Kingdom Kent, United Kingdom Department of Biostatistics and Computational Biology and Department of Neurology, University of Rochester, Rochester, NY, USA Neurorestoration group, King's College, London, United Kingdom School of Behavioral and Brain Sciences, University of Texas at Dallas, TX, USA Department of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Palo Alto, CA, USA Department of Neurobiology, University of Pittsburgh, Pittsburgh, PA, USA Office of Career and Professional Development, University of California San Francisco, San Francisco, CA, USA Faculty of Dentistry & Alan Edwards Centre for Research on Pain, McGill University, Montreal, Canada Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, USA Discovery Research, Purdue Pharma, Cranbury, NJ, USA.

Pain
|December 20, 2015
PubMed
Abstract

Related Concept Videos

Blind Procedures02:07

Blind Procedures

Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
13.9K
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
529